Context Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	42.99	66	94.43	14.45	35.5	49.64
Cash & Short-Term Investments	42.99	66	94.43	14.45	35.5	49.64
Cash Growth	-48.52%	-30.11%	553.50%	-59.29%	-28.48%	16976.13%
Other Current Assets	2.83	2.36	3.47	1.6	2.36	1.62
Total Current Assets	45.82	68.35	97.9	16.05	37.85	51.26
Net Property, Plant & Equipment	0.32	0.14	0.23	0.02	0.08	-
Other Long-Term Assets	-	-	-	-	0.03	0.05
Total Assets	46.13	68.49	98.13	16.06	37.97	51.31
Accounts Payable	3.29	2.53	1.45	2.38	0.94	1.83
Accrued Expenses	4.43	5.38	1.19	1.81	2.22	1.21
Current Portion of Leases	0.17	0.11	0.11	-	0.06	-
Total Current Liabilities	7.88	8.02	2.75	4.19	3.21	3.03
Long-Term Leases	0.08	-	0.11	-	-	-
Total Long-Term Liabilities	0.08	-	0.11	-	-	-
Total Liabilities	7.96	8.02	2.86	4.19	3.21	3.03
Common Stock	0.09	0.09	0.09	0.02	0.02	0.02
Additional Paid-in Capital	192.22	191.29	189.96	79.91	78.83	77.51
Retained Earnings	-154.14	-130.9	-94.78	-68.05	-44.09	-29.25
Total Common Shareholders' Equity	38.17	60.47	95.27	11.87	34.76	48.27
Shareholders' Equity	38.17	60.47	95.27	11.87	34.76	48.27
Total Liabilities & Equity	46.13	68.49	98.13	16.06	37.97	51.31
Total Debt	0.24	0.11	0.22	0	0.06	0
Net Cash (Debt)	42.75	65.88	94.21	14.45	35.44	49.64
Net Cash Growth	-48.72%	-30.07%	551.98%	-59.23%	-28.59%	-
Net Cash Per Share	0.45	0.69	1.61	0.91	2.22	17.52
Book Value	38.17	60.47	95.27	11.87	34.76	48.27
Book Value Per Share	0.40	0.64	1.63	0.74	2.18	17.04
Tangible Book Value	38.17	60.47	95.27	11.87	34.76	48.27
Tangible Book Value Per Share	0.40	0.64	1.63	0.74	2.18	17.04

SEC Filings: 10-K · 10-Q